Skip to content

Opening book details…

About this Medicine article

Can eculizumab be discontinued in aHUS? by Sahutoglu, Tuncay; Basturk, Taner; Sakaci, Tamer; Koc, Yener; Ahbap, Elbis; Sevinc, Mustafa; Kara, Ekrem; Akgol, Cuneyt; Caglayan, Feyza Bayraktar; Unsal, Abdulkadir; Daha, Mohamed R. is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Sahutoglu, Tuncay; Basturk, Taner; Sakaci, Tamer; Koc, Yener; Ahbap, Elbis; Sevinc, Mustafa; Kara, Ekrem; Akgol, Cuneyt; Caglayan, Feyza Bayraktar; Unsal, Abdulkadir; Daha, Mohamed R.
Publisher
Lippincott Williams and Wilkins; Elsevier ; Ovid Technologies (Wolters Kluwer) - Lippincott Williams & Wilkins; Elsevier BV; Lippincott Williams & Wilkins Ltd.; Medicine Publishing Company Ltd; Williams & Wilkins; Ovid Technologies (Wolters Kluwer Health) (ISSN 1357-3039)
Published
2016
Field
Medicine (Health Sciences)

More by Sahutoglu, Tuncay; Basturk, Taner; Sakaci, Tamer; Koc, Yener; Ahbap, Elbis; Sevinc, Mustafa; Kara, Ekrem; Akgol, Cuneyt; Caglayan, Feyza Bayraktar; Unsal, Abdulkadir; Daha, Mohamed R.

Browse all works by Sahutoglu, Tuncay; Basturk, Taner; Sakaci, Tamer; Koc, Yener; Ahbap, Elbis; Sevinc, Mustafa; Kara, Ekrem; Akgol, Cuneyt; Caglayan, Feyza Bayraktar; Unsal, Abdulkadir; Daha, Mohamed R.